REUTERS: Valeant Pharmaceuticals International Inc named Zoetis Inc executive Paul Herendeen as its chief financial officer, replacing Robert Rosiello, the latest in a series of management changes at the Canadian drugmaker. Valeant’s U.S.-listed shares were up 5 percent in premarket trading on Monday.
